The impact of PBRM1 mutations on overall survival in greater than 2,100 patients treated with immune checkpoint blockade (ICB).
暂无分享,去创建一个
R. Motzer | A. Hakimi | I. Ostrovnaya | M. Voss | T. Chan | Chung-Han Lee | M. Carlo | Douglas R. Hoen | V. Makarov | F. Kuo | J. Flynn | Y. Ged | Kyle A. Blum | R. G. D. Natale